| Thu, Jun 25, 2009 | | • | 6 More Stock Briefs
at Seeking Alpha (Thu, Jun 25)
| | Wed, Jun 17, 2009 | | • | Keryx Biopharmaceuticals Inc. Regains Compliance With NASDAQ Listing Requirements
PR Newswire (Wed, Jun 17)
| | Tue, Jun 9, 2009 | | • | KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Other Events
EDGAR Online (Tue, Jun 9)
| | • | Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
PR Newswire (Tue, Jun 9)
| | • | FDA Calendar Updates: Keryx Biopharma Announces Phase 2 Results
at Seeking Alpha (Tue, Jun 9)
| | Mon, Jun 8, 2009 | | • | Movers roundup: Headwaters, Keryx Biopharma
AP (Mon, Jun 8)
| | • | Selected Healthcare Sectors Buck Market Dip
Indie Research (Mon, Jun 8)
| | • | Keryx shares jump on positive Zerenex study
AP (Mon, Jun 8)
| | • | Keryx Biopharmaceuticals Reports Positive Phase 2 Study Results of Zerenex (Ferric Citrate) for the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients
PR Newswire (Mon, Jun 8)
| | Wed, Jun 3, 2009 | | • | Keryx: Another Beneficiary of the ASCO Effect
at Seeking Alpha (Wed, Jun 3)
| | Mon, Jun 1, 2009 | | • | Top Takes From RealMoney
at TheStreet.com (Mon, Jun 1)
| | • | Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
PR Newswire (Mon, Jun 1)
| | Sun, May 31, 2009 | | • | Biotech Orphans Seek Homes
at TheStreet.com (Sun, May 31)
| | • | Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Cancer
PR Newswire (Sun, May 31)
| | Fri, May 29, 2009 | | • | Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
PR Newswire (Fri, May 29)
| | Thu, May 28, 2009 | | • | Top Takes From Real Money
at TheStreet.com (Thu, May 28)
| | • | Healthy Gains for Cancer Treatment Stocks
Indie Research (Thu, May 28)
| | Fri, May 22, 2009 | | • | KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and
EDGAR Online (Fri, May 22)
| | Thu, May 21, 2009 | | • | KERYX BIOPHARMACEUTICALS INC Financials
EDGAR Online Financials (Thu, May 21)
| | Wed, May 20, 2009 | | • | Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer
PR Newswire (Wed, May 20)
|
Add KERX News to My Yahoo!:
 
| |
|
0.06% Nasdaq 0.00%
Headlines
